Latvia vs Mus: TB patients with known HIV status (%)
Latvia
100.0%
in 2024
Mus
100.0%
in 2024
Latvia rank
1st
Mus rank
1st
TB patients with known HIV status (%) over time
- Latvia
- Mus
How they compare
Latvia currently reports 100.0% against 100.0% in Mus, a difference of 0.0%.
The two have swapped places 1 time across 17 shared years of data; in 2003 it was Latvia ahead.
Latvia ranks 1st and Mus ranks 1st of 181 countries.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.4% | 90.0% | 2.6% | Mus |
| 2010s | 74.8% | 95.8% | 21.0% | Mus |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tb patients with known hiv status, Latvia or Mus?
- Latvia, at 100.0% against 100.0% in Mus as of 2024.
- What is the difference in tb patients with known hiv status between Latvia and Mus?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Mus?
- 17 years are reported by both, from 2003 to 2024.
- How do Latvia and Mus rank globally for tb patients with known hiv status?
- Latvia ranks 1st and Mus ranks 1st of 181 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as TB patients with known HIV status (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.